GLP-1 Hub Podcast
GLP-1s and Diabetes: Low Blood Sugar, Meals and Medication Reviews
Dietitian Erin Palinski-Wade explains what changes when GLP-1 care also involves diabetes: glucose monitoring, other medicines, regular meals and realistic goals.
Listen to this episode
The GLP-1 Hub Podcast
When you take a GLP-1 for diabetes, eating less is only one part of the picture. Your glucose pattern, other medicines and ability to recognize and treat a low also matter. Nausea or fatigue should not automatically be dismissed as an expected side effect.
Registered dietitian and certified diabetes care and education specialist Erin Palinski-Wade brings two decades of diabetes work to her conversation with Ana Reisdorf. Her most practical message is to make treatment understandable and manageable, rather than adding more rules to an already demanding daily routine.
Why the rest of your medication list matters
Palinski-Wade explains that many people taking a GLP-1 for diabetes also use other glucose-lowering medicines. When appetite and intake change, a regimen that previously fit may need review.
The risk is not identical for every combination. For example, the Ozempic prescribing information warns that using it with insulin or an insulin secretagogue such as a sulfonylurea increases hypoglycemia risk, including severe episodes. A clinician may need to adjust those medicines. This is more precise than assuming every GLP-1 user will develop dangerous lows, or that no one will.
Bring an up-to-date medication list to the prescriber and ask who will review it when treatment starts, doses change or food intake drops. A lower glucose result can be useful information; it should not lead to an unsupervised decision to stop insulin or another prescribed medicine.
Side effect or low blood sugar? Have a plan before guessing
Shakiness, fatigue and feeling generally unwell can overlap with several problems. Palinski-Wade encourages checking glucose when a person with diabetes feels off, according to their care plan, rather than trying to identify the cause from a symptom alone.
A glucose monitor or continuous glucose monitor can provide useful information, but the right testing schedule is individual. The interview specifically avoids one fixed number of checks for everyone. Ask when to check, what your targets are, how to confirm an unexpected reading and whom to contact for recurrent lows.
NIDDK guidance on hypoglycemia advises prompt treatment when glucose is below your target or under 70 mg/dL. For someone awake and able to swallow, it describes taking 15 to 20 grams of fast-acting glucose or carbohydrate and checking again after 15 minutes, repeating if still low. Your diabetes team should tailor a plan, including the appropriate product for your medicines.
Severe confusion, a seizure or loss of consciousness requires emergency help. Do not give food or drink to someone who cannot safely swallow; prescribed glucagon may be part of their emergency plan. Make sure the people likely to be nearby know what to do. Those details belong in preparation, not in a rushed search after symptoms begin.
Reduced hunger does not remove the need for meals
Palinski-Wade describes the ease of eating breakfast and then forgetting food until dinner when hunger cues are quieter. For a person using medicines that can cause lows, that gap can have consequences beyond falling short of a nutrition target.
She suggests practical reminders and a simple food record. It can be a note or voice memo rather than a detailed calorie spreadsheet. The aim is to notice a repeated gap in intake, connect it with symptoms or glucose readings and bring useful information to care.
A nutrition visit can also address what “enough” looks like when portions are smaller. Palinski-Wade starts with protein and rounds meals out with fiber-containing foods and other components. She does not present one carbohydrate allowance as appropriate for everyone.
Carbohydrate quality and context still count
Ana asks whether diabetes care still centers on counting carbohydrate grams. Palinski-Wade says counting can help someone understand their response, but the amount and distribution need to fit the individual. A bean and a piece of candy should not become interchangeable simply because both contain carbohydrate.
Her emphasis is on the meal: protein, a fiber-containing carbohydrate and some fat, rather than treating carbohydrates as forbidden. A dietitian can help relate that pattern to the person’s glucose data, preferences and medicines.
This is also why a balanced everyday meal is different from emergency treatment for a low. The fast-acting carbohydrate in a hypoglycemia plan serves an immediate purpose; it is not a failure to eat “perfectly.” For more on one part of everyday eating, read Barbara Ruhs on fiber and GLP-1 nutrition.
Diabetes care should not be judged by the scale alone
Palinski-Wade asks clients what their desired weight is supposed to feel like. More energy, lifting something more easily or keeping up with family can make the goal more meaningful. These observations can coexist with glucose and other clinical measures.
A short period without weight loss does not show that all benefit has stopped. Nor does a home body-composition scale prove precisely how much fat or muscle changed. The useful approach is to review patterns and the whole treatment plan rather than escalating restriction after one disappointing measurement.
The interview also touches on GLP-1 use in type 1 diabetes. That requires specialist oversight and should not be read as permission to replace insulin. The MHRA has warned about ketoacidosis after insulin was rapidly reduced or stopped when a GLP-1 was added. Medication changes need a clinician’s plan and monitoring.
Palinski-Wade closes by encouraging small, repeatable changes rather than perfection. That is a useful way to reduce the burden of care, while remembering that glucose outcomes also reflect biology, treatment and access. Needing another adjustment is information for the team, not a judgment about your effort.
The complete conversation
Prefer to read?
Explore the full episode transcript, with speaker labels and the original discussion.
